Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. Its structure supports binding to neurological receptors, making it valuable in creating potential treatments for psychiatric and neurological disorders. The compound's trifluoromethyl group enhances metabolic stability and bioavailability, which is advantageous in drug design. It is also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity of new therapeutic candidates.